Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors

Despite the success of antiestrogens in extending overall survival of patients with estrogen receptor positive (ER+) breast tumors, resistance to these therapies is prevalent. ER+ tumors that progress on antiestrogens are treated with antiestrogens and CDK4/6 inhibitors. However, 20% of these tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallah, Yassi, Demas, Diane M., Jin, Lu, He, Wei, Shajahan-Haq, Ayesha N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281892/
https://www.ncbi.nlm.nih.gov/pubmed/34277427
http://dx.doi.org/10.3389/fonc.2021.681530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281892/
https://www.ncbi.nlm.nih.gov/pubmed/34277427
http://dx.doi.org/10.3389/fonc.2021.681530

Ejemplares similares